Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioma × vorasidenib × Clear all

Status

Recruiting 2 Not yet recruiting 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Glioma 1 Astrocytoma 1

Interventions

Temozolomide 4 vorasidenib 1 trametinib 1 tovorafenib 1 posaconazole 1 perillyl alcohol 1 pembrolizumab 1 niraparib 1 gallium maltolate 1 dabrafenib 1 contrast agent BR1 1 Standard of Care 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Physical Therapy Modalities 1 Nivolumab 1 Microscopy 1 Mental Status and Dementia Tests 1 Lomustine 1 Ketoconazole 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Electrocorticography 1 Electric Stimulation 1 Cyclophosphamide 1 Craniotomy 1 Blood Specimen Collection 1 Biopsy 1 Bevacizumab 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06969352 2025-05-13

VICTORIA

Servier (Tianjin) Pharmaceutical Co. LTD.

Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡